Trexquant Investment’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Buy |
+12,781
| New | +$144K | ﹤0.01% | 1466 |
|
|
2024
Q2 | – | Sell |
-55,444
| Closed | -$658K | – | 1695 |
|
|
2024
Q1 | $658K | Buy |
+55,444
| New | +$658K | 0.01% | 1066 |
|
|
2022
Q3 | – | Sell |
-39,048
| Closed | -$384K | – | 1626 |
|
|
2022
Q2 | $384K | Buy |
+39,048
| New | +$384K | 0.02% | 989 |
|
|
2022
Q1 | – | Sell |
-17,131
| Closed | -$227K | – | 1548 |
|
|
2021
Q4 | $227K | Sell |
17,131
-2,007
| -10% | -$26.6K | 0.01% | 1077 |
|
|
2021
Q3 | $334K | Buy |
+19,138
| New | +$334K | 0.03% | 697 |
|
|
2020
Q3 | – | Sell |
-13,169
| Closed | -$159K | – | 1380 |
|
|
2020
Q2 | $159K | Buy |
+13,169
| New | +$159K | 0.01% | 1075 |
|
|
2019
Q4 | – | Sell |
-15,799
| Closed | -$183K | – | 1154 |
|
|
2019
Q3 | $183K | Buy |
+15,799
| New | +$183K | 0.02% | 766 |
|